Article Text
Abstract
Background The aim of our study was to find predictors of parenchymal hematoma (PH) and clinical outcome after mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) and baseline large infarct.
Methods The databases of 16 stroke centers were retrospectively screened for patients with anterior circulation LVO and baseline Alberta Stroke Program Early CT Score (ASPECTS) ≤5 that received MT. Procedural parameters, including the number of passes during first and second technique of MT, were recorded. Outcome measures were occurrence of PH type 2 and any type of PH after MT, and the 90-day modified Rankin Scale (mRS) score of 0–3 and 0–2.
Results In total, 408 patients were available for analysis. A higher number of passes in the second technique was predictive of PH type 2 (odds ratio (OR) - 3.204, 95% confidence interval (CI) 1.140 to 9.005), whereas procedure conducted under general anesthesia was associated with lower risk (OR 0.127, 95% CI 0.002 to 0.808). The modified thrombolysis in cerebral infarction grade 2c-3 was associated with the mRS score 0–3 (OR 3.373, 95% CI 1.891 to 6.017), whereas occurrence of PH type 2 was predictive of unfavorable outcome (OR 0.221, 95% CI 0.063 to 0.773). Similar results were found for the mRS score 0–2 outcome measure.
Conclusion In patients with large ischemic core, a higher number of passes during MT and procedure not conducted under general anesthesia are associated with increased rate of PH type 2, that negatively impact the clinical outcome. Our data outline a delicate balance between the need of a complete recanalization and the risk of PH following MT.
- Stroke
- Intervention
Data availability statement
Data are available upon reasonable request. The anonymized data that support the results of this study are available on request from the corresponding author.
Statistics from Altmetric.com
Data availability statement
Data are available upon reasonable request. The anonymized data that support the results of this study are available on request from the corresponding author.
Footnotes
Twitter @abroccolini1
AMA and LS contributed equally.
Contributors AMA, LS, VB, IS, EK and AB contributed to the study concept or design, acquisition, analysis and interpretation of data and drafting/revision of the manuscript for content. IV, AC, DDL, GF, FC, MP, CR, AM, MR, EL, JDG, GC, NL, FA, SF, VDR, LB, GS, NM, RR, MB, AAC, SLV, DGR, GFra, VS, MPG, ELo, AR, ACav, LM, MM, FG, LC, contributed to the acquisition, analysis and interpretation of data and revision of the manuscript for content. AP and PC contributed to the study concept or design and to drafting/revision of the manuscript for content. AB is the guarantor.
Funding This work was supported by Ricerca Corrente Reti IRCCS 2022, RCR‐2022‐23682294, Rete IRCCS delle Neuroscienze e della Neuroriabilitazione – RIN, Istituto Virtuale Nazionale Malattie Cerebrovascolari.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.